McNamara's extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise to accelerate Yunu's life sciences business.

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise ...

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion ...

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...

Pratteln, Switzerland, November 12, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive supply agreement with Ali Al Suwaidi Trading Est. (ASTE) for the treatment of ...

STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug, ...

Funding will help organisations amplify the voices of LGBTI communities worldwide in counteracting anti-rights activities, addressing HIV stigma and advancing HIV services and advocacy Commitment ...

ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord ...

Babraham Research Campus Ltd, which is responsible for the development and management of Babraham Research Campus is delighted to announce the appointment of Dr Louise Jopling to the newly created ...

Kancera AB (publ) today announces the decision to focus its business on developing the company’s fractalkine blocking candidate drugs KAND567 and KAND145 to treat cardiovascular diseases, initially ...

Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil ® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients ...

Experienced diabetologist and medical director, Dr. Owen brings to DiogenX over two decades of expertise in diabetes clinical management and drug development, as lead candidate progresses towards ...